Wockhardt shares surged 7.45% to 1,435 following the publication of positive Phase 3 clinical trial results for its novel antibiotic Miqnaf (nafithromycin)
The results of a statewide review of 3.9 lakh lipid profile tests performed in the previous year have been made public by Metropolis Healthcare. According to the study, there has been a worrying change in the cardiovascular landscape of India
Global pharmaceutical giant Lupin Limited disclosed that its wholly owned subsidiary, Nanomi B.V., has executed a definitive agreement to acquire VISUfarma B.V., a specialty eye health company backed by GHO Capital Partners...
Syngene International has achieved a successful scale-up of the synthesis of a new active pharmaceutical ingredient for vascular calcification inhibition, progressing from lab-scale proof-of-concept to commercial-scale good manufacturing...
Moderna has conveyed that the primary immunogenicity data for the 2025-2026 formula of mNEXSPIKE, the mRNA COVID-19 vaccine of their choice to the LP.8.1 variant of SARS-CoV-2, is in the positive range.
The revolutionary change that could dramatically impact the prevention of HIV may well hinge on how fast Indian regulators accept the proposal. Gilead Sciences, a US-based company, gave no-royalty licenses to four Indian firms
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently held a crucial meeting with the NICDC Logistics Data Services Limited (NLDSL) to launch Logistics e-Marketplace (LeMP) and a new under-development portal search engine regard
AbbVie announced that it has officially submitted a NDA to the USFDA for tavapadon, a next generation selective dopamine D1/D5 receptor partial agonist created to be taken once daily for oral administration for the treatment of Parkinson's...
According to the US Food and Drug Administration (USFDA), products of Glenmark, Granules India, Sun Pharma, Zydus, and Unichem have been voluntarily recalled in the United States due to manufacturing deficiencies.
Danish pharmaceutical giant Novo Nordisk is planning to introduce Ozempic (semaglutide) in India, a once-weekly injectable that was initially approved for type-2 diabetes but is getting recognition as a treatment for obesity
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")